Tech Company Financing Transactions
Proteonomix Funding Round
On 3/23/2012, Proteonomix raised $3.8 million in funding from private investors.
Transaction Overview
Company Name
Announced On
3/23/2012
Transaction Type
Venture Equity
Amount
$3,804,991
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
145 Highview Terrace
Hawthorne, NJ 07506
USA
Hawthorne, NJ 07506
USA
Phone
Website
Email Address
Overview
Our mission is to focus upon the development of therapies based upon the use of human stem cells and their derivatives, particularly in the areas of diabetes and cardiac diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Cohen
Chief Scientific Officer
Ian McNiece
Browse more venture capital transactions:
Prev: 3/23/2012: InEnTec venture capital transaction
Next: 3/23/2012: TheraVida venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs